# Rescheduling & Federal Policy Episodes of The Dime Podcast covering Rescheduling & Federal Policy: cannabis business conversations with founders, executives and investors. 54 episodes. - Canonical: https://www.dimepodcast.com/topics/rescheduling-and-federal-policy - Topic index for agents: https://www.dimepodcast.com/topics/rescheduling-and-federal-policy/llms.txt - All topics: https://www.dimepodcast.com/topics ## Analysis on Rescheduling & Federal Policy First Principles essays by Bryan Fields. Human written. - [The Best Asset Is the One That Survives Being Wrong](https://www.dimepodcast.com/newsletter/the-best-asset-is-the-one-that-survives-being-wrong) (October 14, 2026): Reform does not help every cannabis operator equally. Jay Rosenthal on why the best asset is the one that still has value when your forecast is wrong. Markdown: https://www.dimepodcast.com/newsletter/the-best-asset-is-the-one-that-survives-being-wrong.md - [The Cannabis Industry Fought for Medical Access. Why Is It Silent Now?](https://www.dimepodcast.com/newsletter/the-cannabis-industry-fought-for-medical-access-why-is-it-silent-now) (August 4, 2026): The federal hemp ban arrives in November. It was aimed at intoxicating products, but the language is broad enough to take therapeutic CBD with it. Markdown: https://www.dimepodcast.com/newsletter/the-cannabis-industry-fought-for-medical-access-why-is-it-silent-now.md - [The Cannabis Medical Thesis Was Never Wrong. The World Just Forgot.](https://www.dimepodcast.com/newsletter/the-cannabis-medical-thesis-was-never-wrong-the-world-just-forgot) (May 27, 2026): Cannabis started as a medical story, then the green rush buried it. The FDA's botanical drug pathway is what brings the original thesis back. Markdown: https://www.dimepodcast.com/newsletter/the-cannabis-medical-thesis-was-never-wrong-the-world-just-forgot.md - [Let's End the Year of the Prohibitionist.](https://www.dimepodcast.com/newsletter/lets-end-the-year-of-the-prohibitionist) (April 3, 2026): Access is a transaction. Influence is leverage. Cannabis has confused the two, and the scoreboard in Washington keeps saying so. Markdown: https://www.dimepodcast.com/newsletter/lets-end-the-year-of-the-prohibitionist.md - [Optionality Beats Control in Chaos](https://www.dimepodcast.com/newsletter/optionality-beats-control-in-chaos) (March 5, 2026): In stable industries control compounds; in unstable ones flexibility does. Cannabis infrastructure is either a moat or an anchor. Markdown: https://www.dimepodcast.com/newsletter/optionality-beats-control-in-chaos.md - [Before CBD Was a Category, It Was a Medical Necessity](https://www.dimepodcast.com/newsletter/before-cbd-was-a-category-it-was-a-medical-necessity) (January 13, 2026): CBD didn't earn acceptance through branding. It earned it because results showed up where nothing else worked — and Schedule III raises the bar again. Markdown: https://www.dimepodcast.com/newsletter/before-cbd-was-a-category-it-was-a-medical-necessity.md - [CBD: The Gateway Cannabinoid](https://www.dimepodcast.com/newsletter/cbd-the-gateway-cannabinoid) (December 22, 2025): Schedule III put CBD first for a reason: it's the lowest-friction entry point for FDA oversight. The agency will apply the playbook it knows. Markdown: https://www.dimepodcast.com/newsletter/cbd-the-gateway-cannabinoid.md - [The Enemy of My Enemy Is My Friend, Except When It Comes to Cannabinoids](https://www.dimepodcast.com/newsletter/the-enemy-of-my-enemy-is-my-friend-except-when-it-comes-to-cannabinoids) (October 3, 2025): Logic doesn't work in the cannabinoid space. Power and influence do. Spirits, pharma, big ag and retail are all circling the same disruption. Markdown: https://www.dimepodcast.com/newsletter/the-enemy-of-my-enemy-is-my-friend-except-when-it-comes-to-cannabinoids.md - [Why Some Cannabis Research Can't Be Trusted](https://www.dimepodcast.com/newsletter/why-some-cannabis-research-cant-be-trusted) (September 25, 2025): When billions are on the line, research gets messy. Read closely, stay skeptical — and know which meta-analysis actually put the numbers on the table. Markdown: https://www.dimepodcast.com/newsletter/why-some-cannabis-research-cant-be-trusted.md - [THC Is Just an Ingredient — How Schedule III Will Reshape Cannabis, Pharma & Hemp](https://www.dimepodcast.com/newsletter/thc-is-just-an-ingredient-how-schedule-iii-will-reshape-cannabis-pharma-and-hemp) (September 15, 2025): What if cannabis operators had to buy cannabinoids from GMP-licensed manufacturers instead of retrofitting facilities? The supply chain flips overnight. Markdown: https://www.dimepodcast.com/newsletter/thc-is-just-an-ingredient-how-schedule-iii-will-reshape-cannabis-pharma-and-hemp.md ## Episodes - [Who Benefits From Federal Cannabis Limbo? ft. Jay Rosenthal](https://www.dimepodcast.com/episodes/who-benefits-from-federal-cannabis-limbo-ft-jay-rosenthal) — Jay Rosenthal: Jay Rosenthal, co-founder of the cannabis industry newsletter Cultivated, joins Bryan Fields to unpack why federal cannabis reform may actually benefit the biggest MSOs more than it threatens them,… Markdown: https://www.dimepodcast.com/episodes/who-benefits-from-federal-cannabis-limbo-ft-jay-rosenthal.md - [Paige Figi: The Cannabis Industry Is Cheering A Ban On Medicine](https://www.dimepodcast.com/episodes/paige-figi-the-cannabis-industry-is-cheering-a-ban-on-medicine) — Paige Figi: In this episode, Paige Figi — mother of Charlotte Figi, whose story helped launch the modern medical CBD movement — breaks down the looming November 12th federal ban on hemp-derived CBD products and… Markdown: https://www.dimepodcast.com/episodes/paige-figi-the-cannabis-industry-is-cheering-a-ban-on-medicine.md - [Understand This Before You Use AI To Build Software ft. Chris Guthrie](https://www.dimepodcast.com/episodes/understand-this-before-you-use-ai-to-build-software-ft-chris-guthrie) — Chris Guthrie: Chris Guthrie of 365 Cannabis joins the podcast to explain why 'vibe coding' internal ERP, CRM, and supply-chain tools with AI is a tempting but dangerous shortcut for cannabis operators, arguing… Markdown: https://www.dimepodcast.com/episodes/understand-this-before-you-use-ai-to-build-software-ft-chris-guthrie.md - [Hirsh Jain: Rescheduling Is Already Picking Winners](https://www.dimepodcast.com/episodes/hirsh-jain-rescheduling-is-already-picking-winners) — Hirsh Jain: This episode features cannabis strategist Hirsh Jain unpacking the confusing reality behind the April 2025 rescheduling order — explaining why medical cannabis moved to Schedule III while adult-use… Markdown: https://www.dimepodcast.com/episodes/hirsh-jain-rescheduling-is-already-picking-winners.md - [Joe Lustberg: What Cannabis Lenders See That Operators Miss](https://www.dimepodcast.com/episodes/joe-lustberg-what-cannabis-lenders-see-that-operators-miss) — Joe Lustberg: In this episode, Bryan Fields talks with Joe Lustberg of Upwise Capital about what cannabis lenders actually look for versus what operators assume matters, drawing on Joe's dual perspective as a… Markdown: https://www.dimepodcast.com/episodes/joe-lustberg-what-cannabis-lenders-see-that-operators-miss.md - [The Legal Market Was Never Built for Payments, Why Cannabis Still Breaks the Rules ft. Aubrey Amatelli](https://www.dimepodcast.com/episodes/the-legal-market-was-never-built-for-payments-why-cannabis-still-breaks-the-rules-ft-aubrey-amatelli) — Aubrey Amatelli: In this episode, PayRio founder Aubrey Amatelli explains why cannabis payment processing remains fundamentally unstable even for companies that follow every card-network rule, drawing on her own… Markdown: https://www.dimepodcast.com/episodes/the-legal-market-was-never-built-for-payments-why-cannabis-still-breaks-the-rules-ft-aubrey-amatelli.md - [Gretchen Gailey: Cannabis Industry Has No Idea How DC Works, Why Rescheduling Is Delayed](https://www.dimepodcast.com/episodes/gretchen-gailey-cannabis-industry-has-no-idea-how-dc-works-why-rescheduling-is-delayed) — Gretchen Gailey: Longtime Capitol Hill strategist Gretchen Gailey joins Bryan Fields to explain why the cannabis industry's Washington strategy is fundamentally broken, arguing that occasional fly-ins and small… Markdown: https://www.dimepodcast.com/episodes/gretchen-gailey-cannabis-industry-has-no-idea-how-dc-works-why-rescheduling-is-delayed.md - [15 Years of Cannabis Trading . Why I'll Sell Early (Unless This Happens) ft. Dan McDermitt](https://www.dimepodcast.com/episodes/15-years-of-cannabis-trading-why-ill-sell-early-unless-this-happens-ft-dan-mcdermitt) — Dan McDermitt: In this episode, 15-year cannabis stock trading veteran Dan McDermitt of ChartGuys joins host Bryan Fields to break down why the cannabis equity sector remains stuck despite years of rescheduling… Markdown: https://www.dimepodcast.com/episodes/15-years-of-cannabis-trading-why-ill-sell-early-unless-this-happens-ft-dan-mcdermitt.md - [JB (Cheech & Chong CEO): Building a National Cannabis Brand Through Trial, Error & Partnership](https://www.dimepodcast.com/episodes/jb-cheech-chong-ceo-building-a-national-cannabis-brand-through-trial-error-partnership) — Guest: In this episode, JB, CEO of Cheech & Chong, breaks down how the iconic 50-year-old brand built a national cannabis and hemp beverage business through partnership, reverse IP licensing, and… Markdown: https://www.dimepodcast.com/episodes/jb-cheech-chong-ceo-building-a-national-cannabis-brand-through-trial-error-partnership.md - [Hidden Growth Unmasked: Rescheduling, the Farm Bill & What Comes Next ft Trent Woloveck](https://www.dimepodcast.com/episodes/hidden-growth-unmasked-rescheduling-the-farm-bill-what-comes-next-ft-trent-woloveck) — Trent Woloveck: Trent Woloveck of Jushi Holdings joins Bryan Fields to unpack when vertical integration actually pays off versus when it's smarter to lean on distribution, using Jushi's build-out in Virginia and… Markdown: https://www.dimepodcast.com/episodes/hidden-growth-unmasked-rescheduling-the-farm-bill-what-comes-next-ft-trent-woloveck.md - [How Top Teams Balance Art and Process in Extraction ft. Brian Adams](https://www.dimepodcast.com/episodes/how-top-teams-balance-art-and-process-in-extraction-ft-brian-adams) — Brian Adams: In this episode, Brian Adams of Nimbus discusses why rigid, one-size-fits-all extraction SOPs fail in practice, how his team learned to adjust processes based on material variability, and why… Markdown: https://www.dimepodcast.com/episodes/how-top-teams-balance-art-and-process-in-extraction-ft-brian-adams.md - [How Charlotte’s Web Unlocked Medical CBD ft. Bill Morachnick](https://www.dimepodcast.com/episodes/how-charlottes-web-unlocked-medical-cbd-ft-bill-morachnick) — Bill Morachnick: Charlotte's Web CEO Bill Morachnick joins The Dime to tell the origin story behind Charlotte Figi and the company's namesake, and to unpack a newly signed executive order that opens the door to… Markdown: https://www.dimepodcast.com/episodes/how-charlottes-web-unlocked-medical-cbd-ft-bill-morachnick.md - [Schedule III Changes Everything — This Is Just the Beginning](https://www.dimepodcast.com/episodes/schedule-iii-changes-everything-this-is-just-the-beginning) — Guest: This emergency episode of The Dime breaks down the same-day executive order moving cannabis toward Schedule III, featuring cannabinoid manufacturing experts Zach Edge and Matthew Moore of RHO… Markdown: https://www.dimepodcast.com/episodes/schedule-iii-changes-everything-this-is-just-the-beginning.md - [What Tobacco and Alcohol Taught Me About Cannabis. ft. Nick Kenny](https://www.dimepodcast.com/episodes/what-tobacco-and-alcohol-taught-me-about-cannabis-ft-nick-kenny) — Nick Kenny: In this episode of The Dime, hosts Bryan Fields and Kellan Finney sit down with global strategic advisor Nick Kenny, a former tobacco industry marketing executive turned cannabis consultant, to… Markdown: https://www.dimepodcast.com/episodes/what-tobacco-and-alcohol-taught-me-about-cannabis-ft-nick-kenny.md - [$28.4 Billion Dollar Hemp Industry Can’t Be Put Back in the Bottle ft Jim Higdon](https://www.dimepodcast.com/episodes/284-billion-dollar-hemp-industry-cant-be-put-back-in-the-bottle-ft-jim-higdon) — Jim Higdon: This episode of The Dime features Cornbread Hemp co-founder Jim Higdon breaking down the chaotic, fast-moving fight over federal hemp policy, including a bipartisan congressional letter opposing the… Markdown: https://www.dimepodcast.com/episodes/284-billion-dollar-hemp-industry-cant-be-put-back-in-the-bottle-ft-jim-higdon.md - [Largest Medical Cannabis & Cancer Study Ever: Can These Findings Push Rescheduling? ft Ryan Castle](https://www.dimepodcast.com/episodes/largest-medical-cannabis-cancer-study-ever-can-these-findings-push-rescheduling-ft-ryan-castle) — Ryan Castle: This episode of The Dime features Ryan Castle, research director at Whole Health Oncology Institute, discussing the largest medical cannabis and cancer meta-analysis ever conducted — spanning over… Markdown: https://www.dimepodcast.com/episodes/largest-medical-cannabis-cancer-study-ever-can-these-findings-push-rescheduling-ft-ryan-castle.md - [THC Is an Ingredient, Where Pharma, MSOs & Hemp Collide, ft. Zach Edge](https://www.dimepodcast.com/episodes/thc-is-an-ingredient-where-pharma-msos-hemp-collide-ft-zach-edge) — Zach Edge: This episode of The Dime features Zach Edge — a ten-year cannabinoid industry veteran with experience spanning Folium Biosciences, Open Book Extracts, RHO Advisory, and private equity firm Suni —… Markdown: https://www.dimepodcast.com/episodes/thc-is-an-ingredient-where-pharma-msos-hemp-collide-ft-zach-edge.md - [Keep Your Eye on Ohio: Why California’s Failures Are Michigan’s Success, and the Global Cannabis Landscape ft. Hirsh Jain](https://www.dimepodcast.com/episodes/keep-your-eye-on-ohio-why-californias-failures-are-michigans-success-and-the-global-cannabis-landscape-ft-hirsh-jain) — Hirsh Jain: Returning guest Hirsh Jain joins Bryan Fields and Kellan Finney to dissect why California's cannabis market keeps shrinking — high taxes, city opt-outs, and a broken testing regime — while Michigan,… Markdown: https://www.dimepodcast.com/episodes/keep-your-eye-on-ohio-why-californias-failures-are-michigans-success-and-the-global-cannabis-landscape-ft-hirsh-jain.md - [The Cannabis Titanic: The Reset Ahead, Matt Karnes on What the Numbers Say](https://www.dimepodcast.com/episodes/the-cannabis-titanic-the-reset-ahead-matt-karnes-on-what-the-numbers-say) — Matt Karnes: Matt Karnes, founder of GreenWave Advisors and an affiliate partner at Stonehaven, joins Bryan Fields and Kellan Finney to unpack the state of the cannabis industry using his "Titanic" framework:… Markdown: https://www.dimepodcast.com/episodes/the-cannabis-titanic-the-reset-ahead-matt-karnes-on-what-the-numbers-say.md - [Trump, Texas SB3 & the Rescheduling Timeline: Jim Higdon on What Comes Next](https://www.dimepodcast.com/episodes/trump-texas-sb3-the-rescheduling-timeline-jim-higdon-on-what-comes-next) — Jim Higdon: Jim Higdon, co-founder of Cornbread Hemp and the US Hemp Roundtable, joins Bryan Fields and Kellan Finney to unpack Texas Governor Greg Abbott's veto of SB3, the state's proposed near-total THC ban,… Markdown: https://www.dimepodcast.com/episodes/trump-texas-sb3-the-rescheduling-timeline-jim-higdon-on-what-comes-next.md - [The Hidden Weakness in Most Cannabis Operations — What We Heard at Benzinga](https://www.dimepodcast.com/episodes/the-hidden-weakness-in-most-cannabis-operations-what-we-heard-at-benzinga) — Guest: In this two-host episode of The Dime, Bryan Fields and Kellan Finney unpack what they heard behind closed doors at the Benzinga Cannabis Capital Conference, including warning signs of a coming… Markdown: https://www.dimepodcast.com/episodes/the-hidden-weakness-in-most-cannabis-operations-what-we-heard-at-benzinga.md - [Storytelling Is the Future of Cannabis IR ft Jesse Redmond](https://www.dimepodcast.com/episodes/storytelling-is-the-future-of-cannabis-ir-ft-jesse-redmond) — Jesse Redmond: Jesse Redmond, head of investor relations and business development at Leef Brands, returns to The Dime to explain why cannabis IR has become a storytelling exercise — documenting the farm, the… Markdown: https://www.dimepodcast.com/episodes/storytelling-is-the-future-of-cannabis-ir-ft-jesse-redmond.md - [Brett Puffenbarger: The Future of Cannabis Will Look Like This… and Yes, It Will Shock You](https://www.dimepodcast.com/episodes/brett-puffenbarger-the-future-of-cannabis-will-look-like-this-and-yes-it-will-shock-you) — Brett Puffenbarger: Fractional CMO/CRO Brett Puffenbarger — a Marine Corps veteran who cut his teeth opening one of Florida's first dispensaries — joins Bryan Fields and Kellan Finney to argue that most cannabis… Markdown: https://www.dimepodcast.com/episodes/brett-puffenbarger-the-future-of-cannabis-will-look-like-this-and-yes-it-will-shock-you.md - [Big Tobacco Is Moving on Cannabis, the Global Strategy Is Unfolding, and Deepak Anand Reveals Where’s Next](https://www.dimepodcast.com/episodes/big-tobacco-is-moving-on-cannabis-the-global-strategy-is-unfolding-and-deepak-anand-reveals-wheres-next) — Deepak Anand: Global cannabis strategist Deepak Anand joins Bryan Fields and Kellan Finney to map out how Big Tobacco — British American Tobacco, Altria, Philip Morris International, and Japan Tobacco — is quietly… Markdown: https://www.dimepodcast.com/episodes/big-tobacco-is-moving-on-cannabis-the-global-strategy-is-unfolding-and-deepak-anand-reveals-wheres-next.md - [How Leafwell is Disrupting Healthcare: The Data Doctors Can’t Ignore ft. Emily Fisher & Dr June Chin](https://www.dimepodcast.com/episodes/how-leafwell-is-disrupting-healthcare-the-data-doctors-cant-ignore-ft-emily-fisher-dr-june-chin) — Emily Fisher & Dr June Chin: Leafwell co-founder Emily Fisher and Dr. June Chin, a physician and vice chair of New York State's cannabis advisory board, explain how their telehealth platform has grown into a data-driven cannabis… Markdown: https://www.dimepodcast.com/episodes/how-leafwell-is-disrupting-healthcare-the-data-doctors-cant-ignore-ft-emily-fisher-dr-june-chin.md - [The Hard Thing About Hard Things: A Melody of Grit & Fortitude ft. Christina Betancourt Johnson](https://www.dimepodcast.com/episodes/the-hard-thing-about-hard-things-a-melody-of-grit-fortitude-ft-christina-betancourt-johnson) — Christina Betancourt Johnson: Christina Betancourt Johnson, CEO of Standard Wellness Maryland, joins The Dime to unpack what it actually took to build a vertically integrated cannabis company — from a 2017 licensing bet through a… Markdown: https://www.dimepodcast.com/episodes/the-hard-thing-about-hard-things-a-melody-of-grit-fortitude-ft-christina-betancourt-johnson.md - [We Don’t Want Legalization—We Want Decriminalization ft. Luna Stower](https://www.dimepodcast.com/episodes/we-dont-want-legalizationwe-want-decriminalization-ft-luna-stower) — Luna Stower: Cannabis activist and vape-industry veteran Luna Stower joins The Dime to argue that the industry's biggest failure has been chasing "legalization" and commercialization instead of decriminalization,… Markdown: https://www.dimepodcast.com/episodes/we-dont-want-legalizationwe-want-decriminalization-ft-luna-stower.md - [China Tariffs & The Next Era of Vapes: Impact on Supply Chains & Brands ft. Nick Kovacevich](https://www.dimepodcast.com/episodes/china-tariffs-the-next-era-of-vapes-impact-on-supply-chains-brands-ft-nick-kovacevich) — Nick Kovacevich: Nick Kovacevich, corporate relations director at vape hardware maker C-Cell and founder of Kush Bottles, joins The Dime to unpack how a China-based supply chain reshapes the vape industry under new… Markdown: https://www.dimepodcast.com/episodes/china-tariffs-the-next-era-of-vapes-impact-on-supply-chains-brands-ft-nick-kovacevich.md - [Why Cannabis Laws Are a Mess: The Politics and Bureaucracy with Jeff Guillot](https://www.dimepodcast.com/episodes/why-cannabis-laws-are-a-mess-the-politics-and-bureaucracy-with-jeff-guillot) — Jeff Guillot: In this episode of The Dime, hosts Bryan Fields and Kellan sit down with Jeff Guillot, a longtime New York government affairs and lobbying veteran now with MAD Global Strategy, to unpack why cannabis… Markdown: https://www.dimepodcast.com/episodes/why-cannabis-laws-are-a-mess-the-politics-and-bureaucracy-with-jeff-guillot.md - [Navigating the Gray: The Legal Tightrope of Cannabis Risk & Compliance ft. Dan Shapiro](https://www.dimepodcast.com/episodes/navigating-the-gray-the-legal-tightrope-of-cannabis-risk-compliance-ft-dan-shapiro) — Dan Shapiro: In this episode of The Dime, hosts Bryan Fields and Kellan sit down with Dan Shapiro, EVP at Ascend Wellness Holdings, to unpack what it's really like practicing law inside a multi-state cannabis… Markdown: https://www.dimepodcast.com/episodes/navigating-the-gray-the-legal-tightrope-of-cannabis-risk-compliance-ft-dan-shapiro.md - [How Do We Get to a $100 Billion Market? Growth Predictions, Market Consolidations ft Ben Burstein](https://www.dimepodcast.com/episodes/how-do-we-get-to-a-100-billion-market-growth-predictions-market-consolidations-ft-ben-burstein) — Ben Burstein: In this episode of The Dime, Bryan Fields and Kellan Finney sit down with LeafLink's Ben Burstein to unpack the diverging growth narratives between the hemp-derived THC beverage market and the… Markdown: https://www.dimepodcast.com/episodes/how-do-we-get-to-a-100-billion-market-growth-predictions-market-consolidations-ft-ben-burstein.md - [How U.S. Cannabis Legalization Will Shape Global Influence ft. Hirsh Jain](https://www.dimepodcast.com/episodes/how-us-cannabis-legalization-will-shape-global-influence-ft-hirsh-jain) — Hirsh Jain: This episode of The Dime features Hirsh Jain, founder of Anunda Strategy, discussing how U.S. cannabis legalization could shape global drug policy and geopolitical soft power, drawing parallels to… Markdown: https://www.dimepodcast.com/episodes/how-us-cannabis-legalization-will-shape-global-influence-ft-hirsh-jain.md - [Sundie Seefried: Bank Secrecy, Hemp vs. Cannabis Banking, and Credit Card Barriers – What You Need to Know for the Future](https://www.dimepodcast.com/episodes/sundie-seefried-bank-secrecy-hemp-vs-cannabis-banking-and-credit-card-barriers-what-you-need-to-know-for-the-future) — Sundie Seefried: In this episode of The Dime, Sundie Seefried, CEO and President of Safe Harbor Financial, shares how she built one of the first compliant cannabis banking programs in the U.S. starting in 2014, and… Markdown: https://www.dimepodcast.com/episodes/sundie-seefried-bank-secrecy-hemp-vs-cannabis-banking-and-credit-card-barriers-what-you-need-to-know-for-the-future.md - [Behind the Scenes of Cannabis Lobbying: How it REALLY Works ft. The Liaison Group](https://www.dimepodcast.com/episodes/behind-the-scenes-of-cannabis-lobbying-how-it-really-works-ft-the-liaison-group) — Erin Moffet & David Mangone: This episode of The Dime features David Mangone and Erin of The Liaison Group, federal cannabis lobbyists representing the National Cannabis Roundtable, explaining how cannabis lobbying actually… Markdown: https://www.dimepodcast.com/episodes/behind-the-scenes-of-cannabis-lobbying-how-it-really-works-ft-the-liaison-group.md - [How Top Cannabis Companies Keep and Attract Employees ft. Mike Siebold](https://www.dimepodcast.com/episodes/how-top-cannabis-companies-keep-and-attract-employees-ft-mike-siebold) — Mike Siebold: In this episode of The Dime, hosts Bryan Fields and Kellan Finney sit down with Mike Siebold, managing partner at FlowerHire, to unpack how cannabis companies build HR and talent strategy in an… Markdown: https://www.dimepodcast.com/episodes/how-top-cannabis-companies-keep-and-attract-employees-ft-mike-siebold.md - [The Cannabis Industry is Exploding: Here's Why You Are Not Optimistic Enough ft Ben Burstein](https://www.dimepodcast.com/episodes/the-cannabis-industry-is-exploding-heres-why-you-are-not-optimistic-enough-ft-ben-burstein) — Ben Burstein: In this episode of The Dime, LeafLink's Ben Burstein joins hosts Bryan Fields and Kellan Finney to explain why cannabis industry sentiment is far more negative than the underlying data supports,… Markdown: https://www.dimepodcast.com/episodes/the-cannabis-industry-is-exploding-heres-why-you-are-not-optimistic-enough-ft-ben-burstein.md - [Can CBN Replace Melatonin? Results from a Double-Blind Placebo-Controlled Study ft. Alleh Lindquist](https://www.dimepodcast.com/episodes/can-cbn-replace-melatonin-results-from-a-double-blind-placebo-controlled-study-ft-alleh-lindquist) — Alleh Lindquist: This episode of The Dime features Alleh Lindquist, CEO of FlorWorks, discussing how his company built a proprietary, patented CBN compound ("True CBN") and ran a large double-blind,… Markdown: https://www.dimepodcast.com/episodes/can-cbn-replace-melatonin-results-from-a-double-blind-placebo-controlled-study-ft-alleh-lindquist.md - [Mastering Cannabis Storytelling/How to Talk to Your Kids About Cannabis ft. Jordan Isenstadt](https://www.dimepodcast.com/episodes/mastering-cannabis-storytellinghow-to-talk-to-your-kids-about-cannabis-ft-jordan-isenstadt) — Jordan Isenstadt: In this episode of The Dime, hosts Bryan Fields and Kellan Finney sit down with Jordan Isenstadt, Senior VP at PR and marketing agency Marino, to trace how he built one of the cannabis industry's… Markdown: https://www.dimepodcast.com/episodes/mastering-cannabis-storytellinghow-to-talk-to-your-kids-about-cannabis-ft-jordan-isenstadt.md - [How Minor Cannabinoids are Made: Synthetic vs Biosynthetic ft. Shane Johnson](https://www.dimepodcast.com/episodes/how-minor-cannabinoids-are-made-synthetic-vs-biosynthetic-ft-shane-johnson) — Shane Johnson: This episode of The Dime features Shane Johnson, SVP and GM of BayMedica (a subsidiary of InMed Pharmaceuticals), explaining how minor and rare cannabinoids like CBC, CBN, and THCV are produced… Markdown: https://www.dimepodcast.com/episodes/how-minor-cannabinoids-are-made-synthetic-vs-biosynthetic-ft-shane-johnson.md - [Chris Fontes: Cannabis is Already Legal - Hemp vs Cannabis](https://www.dimepodcast.com/episodes/chris-fontes-cannabis-is-already-legal-hemp-vs-cannabis) — Chris Fontes: In this episode of The Dime, Chris Fontes, CEO of High Spirits Beverage and founder of Trojan Horse Cannabis, breaks down how the 2018 Farm Bill's 0.3% delta-9 THC threshold effectively created a… Markdown: https://www.dimepodcast.com/episodes/chris-fontes-cannabis-is-already-legal-hemp-vs-cannabis.md - [Boris Jordan on Curaleaf's European Strategy: Building Coca-Cola of Cannabis](https://www.dimepodcast.com/episodes/boris-jordan-on-curaleafs-european-strategy-building-coca-cola-of-cannabis) — Boris Jordan: In this episode of The Dime, Curaleaf founder and chairman Boris Jordan breaks down the company's US growth catalysts in New York, Ohio, Florida, and Pennsylvania alongside its European expansion… Markdown: https://www.dimepodcast.com/episodes/boris-jordan-on-curaleafs-european-strategy-building-coca-cola-of-cannabis.md - [Pablo Zuanic on Cannabis Stocks: Institutional Strategies for Retail Investors](https://www.dimepodcast.com/episodes/pablo-zuanic-on-cannabis-stocks-institutional-strategies-for-retail-investors) — Pablo Zuanic: In this episode of The Dime, equity analyst Pablo Zuanic of Zuanic & Associates joins hosts Bryan Fields and Kellan Finney to break down how institutional investors think about cannabis stocks,… Markdown: https://www.dimepodcast.com/episodes/pablo-zuanic-on-cannabis-stocks-institutional-strategies-for-retail-investors.md - [Gabe Mendoza: Driving 4Front Ventures Revenue Growth through Innovation from Ideas to Opportunities](https://www.dimepodcast.com/episodes/gabe-mendoza-driving-4front-ventures-revenue-growth-through-innovation-from-ideas-to-opportunities) — Gabe Mendoza: In this episode of The Dime, Gabe Mendoza, EVP of Revenue at 4Front Ventures, walks through his path from winning one of Illinois's first medical cannabis licenses in 2013 to opening 14 dispensaries… Markdown: https://www.dimepodcast.com/episodes/gabe-mendoza-driving-4front-ventures-revenue-growth-through-innovation-from-ideas-to-opportunities.md - [Kim Rivers Discusses Trulieve Preparing for Florida's ~$6 Billion Opportunity](https://www.dimepodcast.com/episodes/kim-rivers-discusses-trulieve-preparing-for-floridas-6-billion-opportunity) — Kim Rivers: In this episode of The Dime, Trulieve CEO Kim Rivers breaks down Florida's path to a potential adult-use cannabis market — including the Smart & Safe Florida ballot initiative, the pending Florida… Markdown: https://www.dimepodcast.com/episodes/kim-rivers-discusses-trulieve-preparing-for-floridas-6-billion-opportunity.md - [Emergency Update: Shane Pennington Breaks Down Cannabis Rescheduling](https://www.dimepodcast.com/episodes/emergency-update-shane-pennington-breaks-down-cannabis-rescheduling) — Shane Pennington: This episode of The Dime features attorney Shane Pennington, partner at Porter Wright, breaking down the federal cannabis rescheduling process in granular detail — from HHS's recommendation and DEA's… Markdown: https://www.dimepodcast.com/episodes/emergency-update-shane-pennington-breaks-down-cannabis-rescheduling.md - [Bradley Nattrass: Applying AgTech Sensors for Automation & Efficiency, The Future Is Now](https://www.dimepodcast.com/episodes/bradley-nattrass-applying-agtech-sensors-for-automation-efficiency-the-future-is-now) — Bradley Nattrass: In this episode of The Dime, Bryan Fields and Kellan Finney sit down with Bradley Nattrass, Chairman and CEO of Urban-gro (NASDAQ: UGRO), a turnkey design-build firm serving the controlled… Markdown: https://www.dimepodcast.com/episodes/bradley-nattrass-applying-agtech-sensors-for-automation-efficiency-the-future-is-now.md - [Do You Have Cannabis DNA? ft. Kmesh](https://www.dimepodcast.com/episodes/do-you-have-cannabis-dna-ft-kmesh) — Kmesh: In this episode of The Dime, hosts Bryan Fields and Kellan sit down with Kmesh, a cannabis industry career coach and founder of KmeshCan, who spent years as an executive recruiter at Flower Hire… Markdown: https://www.dimepodcast.com/episodes/do-you-have-cannabis-dna-ft-kmesh.md - [Charlie Bachtell: The Inside Story of Cresco Labs & Impact of Rescheduling](https://www.dimepodcast.com/episodes/charlie-bachtell-the-inside-story-of-cresco-labs-impact-of-rescheduling) — Charlie Bachtell: In this episode of The Dime, Cresco Labs founder and CEO Charlie Bachtell joins hosts Bryan Fields and Kellen Finney to discuss how the company built its brand-first, data-driven strategy across… Markdown: https://www.dimepodcast.com/episodes/charlie-bachtell-the-inside-story-of-cresco-labs-impact-of-rescheduling.md - [Are Drugs Bad, The Future Cannabinoids as a Medicine 3.0 ft. Dr. Matthew Moore](https://www.dimepodcast.com/episodes/are-drugs-bad-the-future-cannabinoids-as-a-medicine-30-ft-dr-matthew-moore) — Dr. Matthew Moore: In his record third appearance on The Dime, Dr. Matthew Moore joins hosts Bryan Fields and Kellen Finney for a wide-ranging conversation spanning the safety and misuse of psychedelics (sparked by the… Markdown: https://www.dimepodcast.com/episodes/are-drugs-bad-the-future-cannabinoids-as-a-medicine-30-ft-dr-matthew-moore.md - [Why MariMed is Doubling Down on Brand Consistency & the Boston Tea Party-Style 280E Protest ft. Jon Levine](https://www.dimepodcast.com/episodes/why-marimed-is-doubling-down-on-brand-consistency-the-boston-tea-party-style-280e-protest-ft-jon-levine) — Jon Levine: In this episode of The Dime, MariMed CEO Jon Levine joins hosts Bryan Fields and Kellen Finney to discuss stepping into the CEO role after the passing of his best friend and co-founder Bob Fireman,… Markdown: https://www.dimepodcast.com/episodes/why-marimed-is-doubling-down-on-brand-consistency-the-boston-tea-party-style-280e-protest-ft-jon-levine.md - [Emergency NY Update, Unknown Impact of Cannabis Rescheduling & IP Protection ft. Jon Purow](https://www.dimepodcast.com/episodes/emergency-ny-update-unknown-impact-of-cannabis-rescheduling-ip-protection-ft-jon-purow) — Jon Purow: This episode of Dime features cannabis IP attorney Jon Purow of Greenspoon Marder breaking down New York's chaotic Conditional Adult-Use Retail Dispensary (CAURD) rollout, the 'Farmageddon'… Markdown: https://www.dimepodcast.com/episodes/emergency-ny-update-unknown-impact-of-cannabis-rescheduling-ip-protection-ft-jon-purow.md - [The Future of the Industry: State Packs & Market Dynamics, Safe Banking, Capitol Hill Updates ft. Rob Sechrist](https://www.dimepodcast.com/episodes/the-future-of-the-industry-state-packs-market-dynamics-safe-banking-capitol-hill-updates-ft-rob-sechrist) — Rob Sechrist: In this episode of The Dime, Rob Sechrist, co-founder and president of Polaris Capital Group, breaks down how his firm became the first dedicated cannabis real estate lender and pioneered structured… Markdown: https://www.dimepodcast.com/episodes/the-future-of-the-industry-state-packs-market-dynamics-safe-banking-capitol-hill-updates-ft-rob-sechrist.md - [The Art of Connection: Inside The Canna Pac with RW Navis](https://www.dimepodcast.com/episodes/the-art-of-connection-inside-the-canna-pac-with-rw-navis) — Guest: This episode of The Dime features executive recruiter RW Navis, founder of The Canna Pac, discussing the critical difference between true executive headhunting and staffing in the cannabis industry,… Markdown: https://www.dimepodcast.com/episodes/the-art-of-connection-inside-the-canna-pac-with-rw-navis.md - [Matt Zorn: The Attorney Who Sued The DEA and Won](https://www.dimepodcast.com/episodes/matt-zorn-the-attorney-who-sued-the-dea-and-won) — Matt Zorn: In this episode of Dime, hosts Bryan Fields and Kellen Finney talk with attorney Matt Zorn of Yetter Coleman about his string of landmark lawsuits against the DEA on behalf of researcher Dr. Sue… Markdown: https://www.dimepodcast.com/episodes/matt-zorn-the-attorney-who-sued-the-dea-and-won.md --- Markdown variant of any episode, guest, newsletter, answer or topic page on this site: add .md to its URL. Site index: https://www.dimepodcast.com/llms.txt. Complete catalogue: https://www.dimepodcast.com/llms-full.txt